Skip to main content
FQHC Talent

Cookie notice

Allow detailed analytics to improve the site?It's from us, Google and Vercel, and stays off until you accept. If you're signed in, it can link your visits across devices. Declining doesn't limit what you can use. Details & privacy.

Back to the news

HRSA doubles 340B contract pharmacy audits, reviewing 47 entities

Federal

Issue

HRSA has doubled 340B audits of contract pharmacy arrangements, with 47 covered entities under review in the first quarter of 2026. Common problems are duplicate discounts, weak patient eligibility checks and missing pharmacy agreements.

Health centers need real-time eligibility checks and full audit trails, or they risk repayment and suspension.

Key points

  • HRSA doubled 340B audits, with 47 covered entities under review in the first quarter of 2026.
  • Common problems: duplicate discounts, weak eligibility checks and missing pharmacy agreements.
  • Violations can mean repaying the program and suspension.
  • Show real-time eligibility checks, correct split billing and full audit trails.

Sources for this story

HRSA Office of Pharmacy Affairs

Part of

Sources for your board packet

This story's source plus 4 related stories and their sources, ready to print for your team or board.

The newsletter is paused right now. Sign up and you will get it when it starts again.

Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.

Cite this analysis

FQHC Talent. (2026, February 15). HRSA doubles 340B contract pharmacy audits, reviewing 47 entities. Source: HRSA Office of Pharmacy Affairs. Retrieved November 22, 2026, from https://www.fqhctalent.com/intel/340b-audit-wave-contract-pharmacy-2026